Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
ICD-10 C77.4 is a billable code used to indicate a diagnosis of secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes.
C77.4 refers to secondary malignant neoplasms that have metastasized to the inguinal and lower limb lymph nodes. This condition typically arises from a primary cancer located elsewhere in the body, such as the breast, prostate, or melanoma. The inguinal lymph nodes are located in the groin area, while the lower limb lymph nodes include those in the legs. The presence of malignant cells in these lymph nodes indicates advanced disease and often signifies a poor prognosis. Patients may present with swelling, pain, or discomfort in the affected area, and diagnostic imaging or biopsy may be required to confirm the metastatic nature of the disease. Staging of the cancer is crucial, as it helps determine the extent of the disease and guides treatment options. Palliative care considerations are essential for managing symptoms and improving the quality of life for patients with advanced malignancies, focusing on pain management and psychosocial support.
Detailed history of the primary cancer, staging information, and treatment plans.
Patients with known primary cancers presenting with lymphadenopathy in the inguinal region.
Ensure accurate documentation of metastatic disease and treatment response.
Comprehensive symptom management plans and psychosocial assessments.
Patients with advanced cancer requiring symptom relief and end-of-life care.
Focus on quality of life and symptom management documentation.
Used when a biopsy is performed to confirm metastatic disease in lymph nodes.
Pathology report confirming malignancy and documentation of the procedure.
Oncology specialists should ensure thorough documentation of findings.
Coding C77.4 accurately reflects the presence of metastatic disease in the inguinal and lower limb lymph nodes, which is crucial for treatment planning and prognosis.
